Clinical
Research & Trials

We are committed to offering our patients the latest developments in medicine while also providing the highest quality patient care. One of the ways we accomplish this goal is through clinical trials. Clinical trials are at the heart of all medical advances, offering new and innovative solutions to patients that are not widely available to the public.
patient-resources

Pre-clinical studies

Before pharmaceutical/device companies start clinical trials on a drug or device, they conduct extensive animal experiments using wide-ranging doses/ devices to obtain preliminary efficacy and toxicity data.

brand-icon3-grn

Phase I

Phase I trials are referred to as ‘first in humans’. These trials are the first dosage of study drug tested in human subjects. They are designed to test the safety, side effects, dose, and efficacy for the drug. A small group of subjects 2-50 healthy volunteers will be recruited for Phase I.
brand-icon4-grn

Phase II

Once a dose or range of doses is determined, the next goal is to evaluate whether the drug is safe and effect. Phase II trials will recruit between 100 and 300 subjects on average.

Phase II studies are sometimes divided into Phase IIA and Phase IIB. Both studies look to find the optimum dose at which the drug shows effectiveness with minimal side-effects.
brand-icon1-grn

Phase III

Phase III, is designed to assess the effectiveness and safety of the new intervention. Phase III studies are randomized, controlled, large patient groups of 300–3,000 or more and are aimed at being the definitive assessment of how effective the drug is, in comparison with current standard of care.
heart-check-icon-grn

Phase IV

Phase IV trials, are also known as postmarket surveillance trials. They involve the safety surveillance and ongoing technical support of a drug after it receives permission by the FDA to be sold.

Who Can Participate In A Clinical Trial?

All clinical trials have protocols detailing who can participate in the program. Eligibility is determined by assessing age, type of disease, medical history and current medications. Your cardiologist and clinical research coordinator will speak with you to determine your eligibility. Your will be given an informed consent to read and discuss with your family members. The cardiologist and clinical research coordinator will be available to answer any of your questions or concerns.


What Happens During A Clinical Trial?

Your cardiologist and research coordinator will follow your progress throughout the trial. Some trials require EKG’s , Echocardiograms, Lab collection, peripheral vascular studies to name a few. A detailed description of each study visit will be explained within the informed consent.

Interested in Participating in a Clinical Research Trial?

Call Us: 561-537-4778

Focus and Expertise


Research Expertise

Our principal investigators and sub-investigators are all board certified cardiologist with extensive backgrounds in both clinical and academic medicine. Cardiology Partners Clinical Research Institute was created in 2010, to better serve our patient population.


Clinical Research Staff

Our clinical research coordinators and associates include RN’s, ARNP’s, degreed professionals, and certified medical assistants.


High Quality Assessment and Medical Care

We invite established patients to participate in clinical trials, as this allows for continuity of care while enrolled in a clinical research trial.


Adherence to Guidelines

We participate in clinical trials that are approved by the Food and Drug Administration (FDA). Our Physicians, RN’s, ARNP’s, Clinical Research Coordinators and Certified Medical Assistants are trained on all guidelines pertaining to Good Clinical Practice and Protecting Human Subjects participating in Clinical Research Trials. We are trained and certified to ship lab samples according to IATA.


Research at Cardiology Partners Clinical Research Institute

From investigating new diabetes medication effects on cardiovascular outcomes, to new cardiovascular disease treatments, Cardiology Partners Clinical Research Institute’s areas of research include:

  • Diabetes Mellitus (Types I & II) effects on Cardiovascular Outcomes
  • Peripheral Vascular Disease
  • High Cholesterol
  • Congestive Heart Failure
  • Systolic Heart Failure
  • Diastolic Heart Failure
  • Acute Coronary Syndrome
  • Obesity and Cardiovascular Outcomes
  • Novel Oral Anticoagulants
  • Hypertriglyceridemia
  • Microvascular Angina
  • Arrhythmias
  • Device Trials
  • Contact us today to learn more.

Interested in Participating? Contact Us Today to Learn More

care_img2